Patents by Inventor Hollie MCCARRON

Hollie MCCARRON has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Heterocyclic compounds for use in the treatment of cancer
    Patent number: 12358886
    Abstract: The application relates to heterocyclic amide derivatives and their use in the treatment and prophylaxis of cancer, and to compositions containing said derivatives and processes for their preparation.
    Type: Grant
    Filed: August 9, 2019
    Date of Patent: July 15, 2025
    Assignee: Artios Pharma Limited
    Inventors: Peter Blencowe, Mark Charles, Tennyson Ekwuru, Harry Finch, Robert Heald, Hollie McCarron, Martin Stockley
  • HETEROCYCLIC COMPOUNDS FOR USE IN THE TREATMENT OF CANCER
    Publication number: 20230242503
    Abstract: The application relates to heterocyclic amide derivatives and their use in the treatment and prophylaxis of cancer, and to compositions containing said derivatives and processes for their preparation.
    Type: Application
    Filed: August 9, 2019
    Publication date: August 3, 2023
    Applicant: Artios Pharma Limited
    Inventors: Peter BLENCOWE, Mark CHARLES, Tennyson EKWURU, Harry FINCH, Robert HEALD, Hollie MCCARRON, Martin STOCKLEY
  • HETEROCYCLIC COMPOUNDS FOR USE IN THE TREATMENT OF CANCER
    Publication number: 20220298134
    Abstract: The application relates to heterocyclic amide derivatives and their use in the treatment and prophylaxis of cancer, and to compositions containing said derivatives and processes for their preparation.
    Type: Application
    Filed: August 9, 2019
    Publication date: September 22, 2022
    Applicant: Artios Pharma Limited
    Inventors: Peter BLENCOWE, Mark CHARLES, Tennyson EKWURU, Harry FINCH, Robert HEALD, Hollie MCCARRON, Martin STOCKLEY
  • DEUTERATED COMPOUNDS FOR USE IN THE TREATMENT OF CANCER
    Publication number: 20220259174
    Abstract: The application relates to deuterated amide derivatives of formula (I) and their use in the treatment and prophylaxis of cancer, and to compositions containing said derivatives and processes for their preparation.
    Type: Application
    Filed: August 10, 2020
    Publication date: August 18, 2022
    Applicant: Artios Pharma Limited
    Inventors: Peter BLENCOWE, Mark CHARLES, Tennyson EKWURU, Harry FINCH, Hollie MCCARRON, Robert HEALD, Martin STOCKLEY